24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Congress
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:13
Intel’s Israel power plant gets government backing
14:35
How Elon Musk turned the Trump White House into a cash machine
12:05
"Eventually, AI will surpass us in everything"—so what skills will still matter?
09:00
Millions died—but why? Five years later, COVID’s origins remain in dispute
More stories
Buzz
Most popular
Daily
Weekly
1
"Eventually, AI will surpass us in everything"—so what skills will still matter?
2
Armis acquires Otorio for $120 million in latest move toward IPO
3
Ilya Sutskever’s Safe Superintelligence eyes $2B funding as Israeli team quietly grows
4
Intel’s Israel power plant gets government backing
5
Millions died—but why? Five years later, COVID’s origins remain in dispute
More news
Congress
4 stories about Congress
A house divided: Congress shockwaves will hit Israel
05.10.23
|
Adrian Filut
Government bond yields in the US - the security that reflects the level of confidence or lack of confidence in the local economy - jumped this week to a 16-year high and to levels seen immediately before the financial crisis in 2008; The jump in yields makes money more expensive and destabilizes the economy, and it seems that the reasons behind this will not disappear soon
Post-U.S. elections – what can high-tech companies expect?
09.11.20
|
Adv. Joeri Kreisberg and Daniel Ritter
Everyhing from Green Technology, Healthcare, AI, and Space - it's all on the table until 2024
U.S. senators aim to stop sale of drugs online by going after tech's legal immunity
29.09.20
|
Reuters
There are several pieces of legislation targeting Section 230 being introduced from both Democrats and Republicans
U.S. Congress to Investigate Rising Multiple Sclerosis Drug Prices
21.08.17
|
Dror Reich
Two Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies